16-51137264-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002968.3(SALL1):​c.3823G>A​(p.Val1275Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.998 in 1,614,030 control chromosomes in the GnomAD database, including 803,803 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.99 ( 74519 hom., cov: 29)
Exomes 𝑓: 1.0 ( 729284 hom. )

Consequence

SALL1
NM_002968.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.725

Publications

31 publications found
Variant links:
Genes affected
SALL1 (HGNC:10524): (spalt like transcription factor 1) The protein encoded by this gene is a zinc finger transcriptional repressor and may be part of the NuRD histone deacetylase complex (HDAC). Defects in this gene are a cause of Townes-Brocks syndrome (TBS) as well as bronchio-oto-renal syndrome (BOR). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SALL1 Gene-Disease associations (from GenCC):
  • Townes-Brocks syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Townes-Brocks syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.5106074E-7).
BP6
Variant 16-51137264-C-T is Benign according to our data. Variant chr16-51137264-C-T is described in ClinVar as Benign. ClinVar VariationId is 258871.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SALL1NM_002968.3 linkc.3823G>A p.Val1275Ile missense_variant Exon 3 of 3 ENST00000251020.9 NP_002959.2 Q9NSC2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SALL1ENST00000251020.9 linkc.3823G>A p.Val1275Ile missense_variant Exon 3 of 3 1 NM_002968.3 ENSP00000251020.4 Q9NSC2-1

Frequencies

GnomAD3 genomes
AF:
0.990
AC:
150439
AN:
152024
Hom.:
74463
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.964
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.995
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.997
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.993
GnomAD2 exomes
AF:
0.997
AC:
250745
AN:
251490
AF XY:
0.998
show subpopulations
Gnomad AFR exome
AF:
0.961
Gnomad AMR exome
AF:
0.997
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.999
GnomAD4 exome
AF:
0.999
AC:
1460195
AN:
1461888
Hom.:
729284
Cov.:
63
AF XY:
0.999
AC XY:
726514
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.961
AC:
32186
AN:
33478
American (AMR)
AF:
0.997
AC:
44611
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26135
AN:
26136
East Asian (EAS)
AF:
1.00
AC:
39700
AN:
39700
South Asian (SAS)
AF:
1.00
AC:
86248
AN:
86258
European-Finnish (FIN)
AF:
1.00
AC:
53420
AN:
53420
Middle Eastern (MID)
AF:
0.998
AC:
5758
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111904
AN:
1112008
Other (OTH)
AF:
0.997
AC:
60233
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
104
209
313
418
522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21672
43344
65016
86688
108360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.990
AC:
150553
AN:
152142
Hom.:
74519
Cov.:
29
AF XY:
0.990
AC XY:
73641
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.964
AC:
40021
AN:
41502
American (AMR)
AF:
0.995
AC:
15213
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3470
AN:
3470
East Asian (EAS)
AF:
1.00
AC:
5146
AN:
5146
South Asian (SAS)
AF:
1.00
AC:
4788
AN:
4790
European-Finnish (FIN)
AF:
1.00
AC:
10610
AN:
10610
Middle Eastern (MID)
AF:
0.997
AC:
293
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68014
AN:
68028
Other (OTH)
AF:
0.993
AC:
2086
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
73
147
220
294
367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.996
Hom.:
54146
Bravo
AF:
0.989
TwinsUK
AF:
1.00
AC:
3708
ALSPAC
AF:
0.999
AC:
3852
ESP6500AA
AF:
0.966
AC:
4245
ESP6500EA
AF:
1.00
AC:
8600
ExAC
AF:
0.997
AC:
120985
Asia WGS
AF:
0.998
AC:
3472
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
1.00

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Townes-Brocks syndrome 1 Benign:3
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 21, 2017
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Townes syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
4.6
DANN
Benign
0.88
DEOGEN2
Benign
0.14
.;T
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.17
T;T
MetaRNN
Benign
5.5e-7
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.95
.;N
PhyloP100
0.72
PROVEAN
Benign
0.34
N;N
REVEL
Benign
0.14
Sift
Benign
0.84
T;T
Sift4G
Benign
0.48
T;T
Polyphen
0.0
.;B
Vest4
0.052
MPC
0.16
ClinPred
0.0011
T
GERP RS
3.5
Varity_R
0.044
gMVP
0.18
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4614723; hg19: chr16-51171175; COSMIC: COSV107229099; COSMIC: COSV107229099; API